Stratagene is still in negotiations with an unnamed partner to further develop the firm's MX3005 QPCR instrument for molecular diagnostic applications, but the nature of that deal has changed, according to Chairman and CEO Joe Sorge.
...and receive Daily News bulletins.
Already have an account?Login Now.
US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.
Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.
In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.
In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.